🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK NHS GLP-1 prescribing — 12 month update Page 5

UK NHS GLP-1 prescribing — 12 month update

emily_PDX Fri, Jul 25, 2025 at 1:29 AM 28 replies 1,548 viewsPage 5 of 6
wanda_boise
Member
412
1,890
Aug 2024
Boise, ID
Jul 25, 2025 at 8:34 AM#21

Just wanted to say — for anyone reading this UK NHS GLP-1 thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Jul 25, 2025 at 1:34 PM
12 16DanielChem_CHI, marco_milano, pam_columbus and 9 others
Reply Quote Save Share Report
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Jul 25, 2025 at 8:51 AM#22

Want to share my personal experience related to UK NHS GLP-1 prescribing 12 since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 265 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 8 months later: I am down 55 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The UK NHS GLP-1 aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

3 10TinaHashiRN, robert_kc, dan_philly
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Jul 25, 2025 at 9:08 AM#23

Clinical perspective on UK NHS GLP-1 prescribing 12 month:

I have managed ~150 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that the medication works best as part of a comprehensive approach.

For this specific question, I would recommend: getting comprehensive baseline labs first.

Last edited: Jul 25, 2025 at 11:08 AM
11 15tane_welly, Dr.PathRoch, mona_PHX and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SurmountFan_IN
Member
789
3,456
May 2024
Indianapolis, IN
Jul 25, 2025 at 9:25 AM#24

Thank you tommy_boulder! This is incredibly helpful. Bookmarking for later. 🙏

Last edited: Jul 25, 2025 at 10:25 AM
33 1rachel_ABQ, traveltech_sara, AttorneyGrant and 30 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Jul 25, 2025 at 9:42 AM#25

Relevant to UK NHS GLP-1 prescribing 12 — here is my latest bloodwork comparison:

Key improvements: A1C 7.6% → 5.5%, triglycerides 213 → 113 mg/dL, hsCRP 8.0 → 1.3 mg/L. All on tirzepatide for 17 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

17 8mike_nyc, VendorMark, COA_Karl and 14 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register